1999
DOI: 10.2486/indhealth.37.440
|View full text |Cite
|
Sign up to set email alerts
|

Different Change Patterns of the Isozymes of Cytochrome P450 and Glutathione S-Transferases in Chemically Induced Liver Damage in Rat.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
8
0

Year Published

2004
2004
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(10 citation statements)
references
References 30 publications
(1 reference statement)
2
8
0
Order By: Relevance
“…Furthermore, it is well characterized that sustained ROS challenge aggravated cell viability when the activity of CYP2E1 was increased by chemical inducers or enzyme overexpression [54]. In an effort to find the link of hepatocyte death to CYP2E1-dependent metabolism, we measured CYP2E1 protein and mRNA levels after DMF and/or CCl 4 treatment; DMF treatment at the daily dose of 500 mg/kg for 3 days increased the expression of the CYP2E1 level (~1.5-fold), which is consistent with the report that DMF induced CYP2E1 expression [55,56]. CCl 4 is known to reduce CYP2E1 levels by producing reactive metabolites and the consequent suicide substrate inhibition [57].…”
Section: Potential Mechanism Of Dmf-induced Liver Toxicitysupporting
confidence: 85%
“…Furthermore, it is well characterized that sustained ROS challenge aggravated cell viability when the activity of CYP2E1 was increased by chemical inducers or enzyme overexpression [54]. In an effort to find the link of hepatocyte death to CYP2E1-dependent metabolism, we measured CYP2E1 protein and mRNA levels after DMF and/or CCl 4 treatment; DMF treatment at the daily dose of 500 mg/kg for 3 days increased the expression of the CYP2E1 level (~1.5-fold), which is consistent with the report that DMF induced CYP2E1 expression [55,56]. CCl 4 is known to reduce CYP2E1 levels by producing reactive metabolites and the consequent suicide substrate inhibition [57].…”
Section: Potential Mechanism Of Dmf-induced Liver Toxicitysupporting
confidence: 85%
“…Of note, nephrotoxicant induced‐heightened expression of Spp1 in kidney has been reported by others (Wang et al ., 2008). Gstp1, an important member of the glutathione family involved in drug metabolism (Wang et al ., 1999), has also been previously implicated (clinically) in renal disease (Agrawal et al ., 2007). Cluster analyses also led to the identification of changes in gene expression of Cyp3a1 in liver as a possible ‘fingerprint’ of drug‐induced hepatotoxicity.…”
Section: Discussionmentioning
confidence: 99%
“…33 No. 3 ously reported experimental studies that repeated inhalation exposure to and oral administration of DMF for up to 13 weeks induce centrilobular hypertrophy and necrosis of hepatocytes and increased cytolytic release of ALT and aspartate transaminase (AST) into plasma (Lundberg et al, 1981;Craig et al, 1984;Kennedy Jr. et al, 1986;Wang et al, 1999;Chieli et al, 1995;Lynch et al, 2003, Senoh et al, 2003. In addition, some of these studies demonstrated that a proliferative lesion including to DMF (Lynch et al, 2003;Senoh et al, 2003).…”
Section: Note2mentioning
confidence: 99%
“…Medical case reports, epidemiological studies and experimental toxicology studies on health or toxic effects of DMF revealed that DMF primarily affects the liver in humans Wang et al, 1991;Redlich et al, 1990;Fiorito et al, 1997;Nomiyama et al, 2001) and in experimental animals (Lundberg et al, 1981;Craig et al, 1984;Kennedy Jr. et al, 1986;Wang et al, 1999;Chieli et al, 1995;Lynch et al, 2003;Senoh et al, 2003;Malley et al, 1994;Senoh et al, 2004). The International Agency for Research on Cancer (IARC, 1999) made an carcinogenicity to humans (Group 3).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation